Conformis Announces License Agreement with Paragon 28
April 19, 2021 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a...
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
April 07, 2021 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the...
Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
January 21, 2021 16:15 ET
|
Conformis, Inc.
BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical...
Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference
November 24, 2020 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
Conformis Reports Preliminary Third Quarter Revenue Results
October 06, 2020 07:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020. Expected...
Conformis Announces 510(k) Clearance for Cordera™ Hip System
September 29, 2020 10:45 ET
|
Conformis, Inc.
BILLERICA, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s new Cordera™ Hip...
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
September 24, 2020 07:00 ET
|
Conformis, Inc.
BILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to...
Conformis Announces Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund
December 18, 2018 14:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,...
Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants
October 16, 2017 08:00 ET
|
ConforMIS, Inc
BILLERICA, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique...
ConforMIS to Host Third Quarter 2017 Financial Results Conference Call and Webcast on November 1, 2017
October 12, 2017 16:05 ET
|
ConforMIS, Inc
BILLERICA, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, November 1, 2017, at 4:30 p.m. Eastern Time to...